ArticleJournal of medicinal chemistry2014

Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.

Agustin H Mohedas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.